Definitive Healthcare announced the launch of Carevoyance, an innovative sales enablement solution tailored for medtech organizations. Acquired by Definitive Healthcare in January 2024, Carevoyance tackles frontline sales challenges head-on. It’s a powerful sales acceleration engine that enables medical technology sales and marketing teams to streamline time-consuming tasks, including sifting through data to identify target markets, researching potential customers, and automating reports for strategic sales conversations. This translates to faster sales cycles, more targeted outreach, and ultimately, getting life-saving devices to patients more quickly.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on DH:
- VML and Definitive Healthcare announce partnership to transform key opinion leader management
- Definitive Healthcare management to meet virtually with Needham
- Definitive Healthcare earns 2024 Middle Market Leader Award from Boston Business Journal
- Definitive Healthcare price target raised to $11 from $10 at Barclays
- Definitive Healthcare Reports Financial Results for Fourth Quarter and Full Fiscal Year 2023
